Digital Library
Close Browse articles from a journal
 
<< previous    next >>
     Journal description
       All volumes of the corresponding journal
         All issues of the corresponding volume
           All articles of the corresponding issues
                                       Details for article 90 of 459 found articles
 
 
  150MO Safety results from the phase IIIb SIERRA study of durvalumab (D) and tremelimumab (T) as first-line (1L) treatment (tx) for hepatocellular carcinoma (HCC) participants (pts) with a poor prognosis
 
 
Title: 150MO Safety results from the phase IIIb SIERRA study of durvalumab (D) and tremelimumab (T) as first-line (1L) treatment (tx) for hepatocellular carcinoma (HCC) participants (pts) with a poor prognosis
Author: Chan, S.L.
Kudo, M.
Sangro, B.
Kelley, R.K.
Kim, J.H.
Van Binh, P.
Hong, J.Y.
Waldschmidt, D.T.
Marino, D.
Gerolami, R.
Li, Q.
Nakamura, H.
Sun, P.
Baur, B.
Rimassa, L.
Appeared in: Annals of oncology
Paging: Volume 36 () nr. S1 pages S63-S64
Year: 2025
Contents:
Publisher: Published by Elsevier B.V.
Source file: Elektronische Wetenschappelijke Tijdschriften
 
 

                             Details for article 90 of 459 found articles
 
<< previous    next >>
 
 Koninklijke Bibliotheek - National Library of the Netherlands